Purple Biotech PPBT
NASDAQ PPBT
$1.51 -0.01 (-0.66%)
At close: Oct 2, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Cash from Discontinued Operations (2021)

Updated

Purple Biotech (PPBT) posted Cash from Discontinued Operations of -$374,000 for Q4 2021.

Analysis

Purple Biotech (PPBT) Cash from Discontinued Operations (2021) Analysis & Trends

Since Q1 2021, Purple Biotech has reported Cash from Discontinued Operations for 4 quarters.

  • In prior years, Purple Biotech's Cash from Discontinued Operations was $1.71 million in FY2020 and -$1.97 million in FY2019.
  • According to Business Quant data, Cash from Discontinued Operations for the three prior quarters was -$33,000 (Q3 2021), $24,000 (Q2 2021) and -$155,000 (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.87 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Purple Biotech 247,575.07 189,575.07 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -374,000.00
Sep 30, 2021 -33,000.00
Jun 30, 2021 24,000.00
Mar 31, 2021 -155,000.00
API Access

Purple Biotech Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=PPBT&period=max&api_key=YOUR_API_KEY